Co-blockade of immune checkpoints and adenosine A receptor suppresses metastasis.

Oncoimmunology

Immunology in Cancer and Infection Laboratory and Cancer Immunoregulation and Immunotherapy Laboratories; QIMR Berghofer Medical Research Institute ; Herston, Queensland, Australia ; School of Medicine, University of Queensland ; Herston, Queensland, Australia.

Published: November 2014

Immunosuppressive pathways active within the tumor microenvironment must be targeted in combination to sufficiently bolster antitumor immune defenses. Inhibition of A adenosine receptor signaling in combination with immune checkpoint blockade enhances CD8 T and NK cell anti-metastatic activity. This results in reduced metastatic burden and improved survival in pre-clinical models.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4292728PMC
http://dx.doi.org/10.4161/21624011.2014.958952DOI Listing

Publication Analysis

Top Keywords

adenosine receptor
8
co-blockade immune
4
immune checkpoints
4
checkpoints adenosine
4
receptor suppresses
4
suppresses metastasis
4
metastasis immunosuppressive
4
immunosuppressive pathways
4
pathways active
4
active tumor
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!